Androgenetic Alopecia
📧 Sign up to get email alerts when something new happens for Androgenetic Alopecia.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2010-06-10FDA Approved: FINASTERIDE — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for Finasteride from Aurobindo Pharma Limited under their ANDA. This approves the generic Finasterid…
-
FDA approval · 2010-06-07FDA Approved: FINASTERIDE — Original Application (Camber Pharmaceuticals, Inc.)
FDA approved Camber Pharmaceuticals' original ANDA for finasteride, making a generic version of the drug available.
-
FDA approval · 2010-05-27FDA Approved: FINASTERIDE — Supplemental Application (Dr. Reddy's Laboratories Limited)
FDA approves a supplemental application for finasteride submitted by Dr. Reddy's Laboratories Limited, updating the regulatory status of thi…
-
FDA approval · 2010-05-26FDA Approved: FINASTERIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a supplemental application for Teva's generic finasteride, enabling continued marketing of the product.
-
FDA label_change · 2010-03-24FDA Approved: PROPECIA — Supplemental Application (Organon LLC)
The FDA approved a supplemental application for PROPECIA (finasteride) submitted by Organon LLC, resulting in changes to the product labelin…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2010-03-23FDA Approved: PROSCAR — Supplemental Application (Organon LLC)
The FDA has approved a supplemental application for PROSCAR (finasteride) submitted by Organon LLC.
-
FDA approval · 2010-02-23FDA Approved: FINASTERIDE — Original Application (Accord Healthcare, Inc.)
FDA approves Accord Healthcare's generic finasteride through an Original Application for the treatment of benign prostatic hyperplasia and a…
-
CLINICAL_TRIALS trial_result · 2010-01-20Clinical Trial Update: Association of Polymorphisms in the Androgen Receptor Gene and Finasteride Response in Women With Androgenetic Alopecia [Phase 1]
Phase 1 study evaluating whether polymorphisms in the androgen receptor gene influence finasteride response in women with androgenetic alope…
-
CLINICAL_TRIALS trial_result · 2009-08-25Clinical Trial Update: Treatment of Male Pattern Baldness With Botulinum Toxin [Phase 2]
A Phase 2 trial evaluating botulinum toxin for androgenetic alopecia (male pattern baldness) has completed, reporting the study results.
-
CLINICAL_TRIALS trial_result · 2009-04-22Clinical Trial Update: A Study To Assess The Efficacy And Safety Of Dutasteride 0.5mg Once Daily For 6 Months In The Treatment Of Male Subjects With Androgenetic Alopecia [Phase 3]
A Phase 3 clinical trial evaluating dutasteride 0.5 mg daily for six months in men with androgenetic alopecia has completed with results pos…
-
FDA approval · 2008-10-08FDA Approved: HAIR REGROWTH TREATMENT — Supplemental Application (CVS Pharmacy)
FDA approved a supplemental application for a minoxidil-based hair regrowth treatment from CVS Pharmacy under ANDA075357.
-
FDA approval · 2008-08-07FDA Approved: FINASTERIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
The FDA approved a supplemental application for finasteride by Teva Pharmaceuticals USA, Inc., finalizing an update to an existing generic f…
-
FDA approval · 2008-07-21FDA Approved: MEMBERS MARK HAIR REGROWTH TREATMENT — Supplemental Application (Sam's West Inc)
FDA supplemental approval for MEMBERS MARK HAIR REGROWTH TREATMENT (minoxidil) by Sam's West Inc. It applies to a hair regrowth product for …
-
CLINICAL_TRIALS trial_result · 2008-05-20Clinical Trial Update: Efficacy Study of Topical NEOSH101 to Treat Male Pattern Hair Loss [Phase 2]
Phase 2 efficacy study of topical NEOSH101 for male pattern hair loss has completed.
-
CLINICAL_TRIALS trial_result · 2008-05-20Clinical Trial Update: Dose-Ranging Efficacy Study of Topical NEOSH101 to Treat Male Pattern Hair Loss [Phase 2]
Update on a Phase 2 dose-ranging trial evaluating the topical NEOSH101 for male pattern hair loss (androgenetic alopecia) by Neosil, Inc.; t…
-
FDA approval · 2007-11-09FDA Approved: SANTO REMEDIO MENS HAIR REGROWTH TREATMENT MINOXIDIL TOPICAL SOLUTION EXTRA STRENGTH UNSCENTED — Original Application (SANTO REMEDIO LLC)
FDA approved Santo Remedio LLC's original ANDA for minoxidil topical products for hair regrowth, including 2% unscented solution and extra-s…
-
FDA approval · 2007-10-30FDA Approved: FINASTERIDE — Original Application (Aurobindo Pharma Limited)
FDA approved the original application for a generic finasteride manufactured by Aurobindo Pharma Limited.
-
FDA approval · 2007-10-01FDA Approved: FINASTERIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approves a supplemental application for finasteride by Teva Pharmaceuticals USA, Inc., confirming the generic product's approval under a…
-
FDA approval · 2007-02-28FDA Approved: FINASTERIDE — Original Application (Dr. Reddy's Laboratories Limited)
FDA approves Dr. Reddy's Laboratories' generic finasteride (Original Application) for indications including benign prostatic hyperplasia and…
-
CLINICAL_TRIALS research · 2007-01-04Clinical Trial Update: Topical AS101 for Treatment of FAGA (Female Androgenetic Alopecia) in Menopause Women [Phase 2]
Phase 2 clinical trial update evaluating topical AS101 for female androgenetic alopecia in menopausal women. Sponsor: Rabin Medical Center; …
-
FDA approval · 2006-12-15FDA Approved: FINASTERIDE — Original Application (Teva Pharmaceuticals USA, Inc.)
The FDA approved a generic version of finasteride through an original application submitted by Teva Pharmaceuticals USA, Inc.
-
FDA approval · 2006-11-01FDA Approved: PROPECIA — Supplemental Application (Organon LLC)
FDA approves a supplemental application for PROPECIA (finasteride) submitted by Organon LLC.
-
FDA label_change · 2006-09-12FDA Approved: MENS ROGAINE EXTRA STRENGTH UNSCENTED — Supplemental Application (Kenvue Brands LLC)
The FDA approved a supplemental application to add the Men’s Rogaine Extra Strength Unscented minoxidil product (5% topical solution) by Ken…
-
FDA approval · 2006-07-28FDA Approved: FINASTERIDE — Original Application (Dr. Reddy's Laboratories Limited)
FDA approves Dr. Reddy's Laboratories' generic finasteride as an original ANDA (ANDA 076436).
-
FDA label_change · 2006-05-22FDA Approved: WOMENS ROGAINE UNSCENTED — Supplemental Application (Kenvue Brands LLC)
FDA approved a supplemental application for Women's Rogaine Unscented (minoxidil) from Kenvue Brands LLC, updating the product labeling to r…